[1]Léauté-Labrèze C,Prey S,Ezzedine K.Infantile haemangioma:Part I. Pathophysiology,epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011; 25(11): 1245-1253.
[2]Waner M, North PE, Scherer KA, et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol. 2003; 139(7):869-875.
[3]Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150(3): 291-294.
[4]Barnés CM, Christison-Lagay EA, Folkman J. The Placenta Theory and the Origin of Infantile Hemangima. Lymphat Res Biol. 2007;5(4):245-255.
[5]Itinteang T, Tan ST, Brasch HD, et al. Infantile haemangioma expresses embryonic stem cell markers. J Clin Pathol. 2012; 65(5):394-398.
[6]Errani C,Sung YS,Zhang L,et al.Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints. Cancer Genet. 2012; 205 (1-2): 12-17.
[7]Antonescu CR, Le Loarer F, Mosquera JM, et al. Novel YAP1-TFE3 Fusion Defines a Distinct Subset of Epithelioid Hemangioendothelioma. Genes Chromosomes Cancer. 2013; 52(8):775-784.
[8]Qian H, Tryggvason K, Jacobsen SE, et al. Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. Blood. 2006;107(9):3503-3510.
[9]Smadja DM, Guerin CL, Boscolo E, et al. α6-Integrin is Required for the Adhesion and Vasculogenic Potential of Hemangioma Stem Cells. Stem Cells. 2014;31(3): 684-693.
[10]Moser M, Bauer M, Schmid S, et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med. 2009;15(3):300-305.
[11]Smadja DM, Mulliken JB, Bischoff J. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol.2012 ; 181(6): 2239-2247.
[12]Schindler U, Baichwal VR. Three NF-kappa B binding sites in the expression. Mol Cell Biol. 1994;14(9):5820-5831.
[13]Tabatabai G, Herrmann C, von Kürthy G. et al. VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells. Brain. 2008;131(Pt 10):2579-2595.
[14]Yu Y, Flint AF, Mulliken JB, et al. Endothelial progenitor cells in infantile hemangioma. Blood. 2004;103(4):1373-1375.
[15]Oh IY, Yoon CH, Hur J, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood. 2007 ;110(12):3891-3899.
[16]Khan ZA, Boscolo E, Picard A, et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008;118(7):2592-2599.
[17]Boscolo E, Stewart CL, Greenberger S, et al. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/ vascular smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol. 2011; 31(10):2181-2192.
[18]Boscolo E, Mulliken JB, Bischoff J. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma. Am J Pathol. 2011; 179(5):2266-2277.
[19]Boscolo E,Bischoff J.Vasculogenesis in Infantile Hemangioma.Angiogenesis. 2009;12(2):197-207.
[20]Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009; 10(3):165-177.
[21]Koh GY. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 2013;19(1):31-39.
[22]Bischoff J. Progenitor cells in infantile hemangioma. J Craniofac Surg. 2009;20(5): 1629-1630.
[23]Chang EI, Chang EI, Thangarajah H, et al. Hypoxia, hormones,and endothelial progenitor cells in hemangioma. Lymphat Res Biol. 2007;5(4):237-243.
[24]Przewratil P, Sitkiewicz A, Andrzejewska E. local serum level of vessel endothelial gorwth factor in infantile hemangioma. intriguing mechanism of endothelia growth. Cytokine. 2010; 49(2):141-147.
[25]Bautch VL. VEGF-directed blood vessel patterning: from cells to organism. Cold Spring Harbor Perspect Med. 2012;2(9):a006452.
[26]Przewratil P1, Sitkiewicz A, Andrzejewska E. Serum levels of basic fibroblastic growth factor (bFGF) in children with vascular anomalies: Another insight into endothelial growth. Clin Biochem. 2010 ;43(10-11):863-867.
[27]Zengin E,Chalajour F,Geling UM, et al. Vascular wall resident progenitor cells:a source for postnatal vasculogenesis. Development. 2006;133(8):1543-1551.
[28]Medici D, Olsen BR. Rapamycin inhibits proliferation of hemangi- oma endothelial cells by reducing HIF-1-dependent expression of VEGF. PLoS ONE. 2012;7(8):e42913.
[29]Eichmann A, Simons M. VEGF signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol 2012; 24(2):188-193.
[30]Ji Y, Chen S, Li K, et al. Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells. Br J Dermatol. 2014;170(1):78-86.
[31]Kumar P, Miller AI, Polverini PJ. p38 MAPK mediates gamma- irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway.J Biol Chem. 2004;279(41):43352-43360.
[32]Koide M, Ikeda K, Akakabe Y, et al. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells. Proc Natl Acad Sci USA. 2011;108(23):9472-9477.
[33]Lee J Jr, Chen CH, Chen YH,et al. COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2. PLoS One. 2013;8(2):e56211.
[34]Léauté-Labrèze C, Dumas de la Roque E, Hubiche T,et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651.
[35]Itinteang T, Brasch HD, Tan ST, et al. Expression of components of the renin-angiotensin system in proliferating hemangioma may count for the propranolol-induced accelarated involution. J Plast Reconstr Aesthet Surg. 2011; 64(6):759-765.
[36]Park SY, Kang JH, Jeong KJ et al. Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible fac- tor-1alpha protein-dependent mechanism. Int J Cancer. 2013;128(10):2306-2316.
[37]Hadaschik E, Scheiba N, Engstner M, et al. High levels of beta2- adrenoceptors are expressed in infantile capillary hemangiomas and may mediate the therapeutic effect of propranolol. J Cutan Pathol. 2012;39(9) :881-883.
[38]Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93(6):2357-2364.
[39]Chim H, Armijo BS, Miller E, et al. Propranolol Induces Regression of Hemangioma Cells Through HIF-1α–Mediated Inhibition of VEGF-A. Ann Surg. 2012;256(1):146-156.
[40]Christou EM, Wargon O. Effect of captopril on infantile haemangiomas: A retrospective case series. Australas J Dermatol. 2012;53(3):216-218.
[41]Stiles JM, Amaya C, Rains S , et al. Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma. PLoS One. 2013;8(3):e60021.
[42]Ji Y, Chen S, Li K et al. The role of beta-adrenergic receptor signaling in the proliferation of hemangioma-derived endothelial cells. Cell Div. 2013;8(1):1-11.
[43]Herbert A, Ng H, Jessup W,et al. Hypoxia regulates the production and activity of glucose transporter-1 and indoleamine 2,3-dioxygenase in monocyte-derived endothelial-like cells: possible relevance to infantile haemangioma pathogenesis. Br J Dermatol. 2011;164(2): 308-315.
[44]Smoller BR, Apfelberg DB. Infantile (juvenile)capillary hemangioma:A tumor of heterogeneous cellular elements. J Cutan Pathol. 1993;20(4):330-336.
[45]Boscolo E, Mulliken JB, Bischoff J. Pericytes from infantile heman- gioma display proangiogenic properties and dysregulated angiopoietin-1. Arterioscler Thromb Vasc Biol. 2013;33(3):501-509.
[46]Frischer JS, Huang J, Serur A, et al. Biomolecular markers and involution of hemangiomas. J Pediatr Surg. 2004;39(3): 400-404.
[47]Papandreou I, Lim AL, Laderoute K, et al. Hypoxia signals autophagy in tumor cells via AMPK activity,independent of HIF-1,BNIP3,and BNIP3L. Cell Death Differ. 2008;15(10): 1572-1581.
[48]Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274-293.
[49]Chen G, Zhang W, Li YP,et al. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma? Cardiovasc Res. 2013;98(3): 437-448.
[50]Greenberger S, Yuan S, Walsh LA, et al. Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma. J Invest Dermatol. 2011;131(12):2467-2476.
[51]Wu JK, Adepoju O, De Silva D, et al. A switch in Notch gene expression parallels stem cell to endothelial transi- tion in infantile hemangioma. Angiogenesis. 2010;13(1):15-23.
[52]Jia J, Zhao YF, Zhao JH. Potential roles of allograft in?ammatory factor-1 in the pathogenesis of hemangiomas. Med Hypotheses. 2007;68(2):288-290.
[53]Lazaridou E, Giannopoulou C, Apalla Z,et al. Calcineurin inhibitors in the treatment of cutaneous infantile haemangiomas. J Eur Acad Dermatol Venereol. 2010;24(5): 614-615.
[54]Yu Y, Fuhr J, Boye E, et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells. 2006; 24(6):1605-1612.
[55]Itinteang T, Vishvanath A, Day DJ, et al. Mesenchymal stem cells in infantile haemangioma. J Clin Pathol. 2011;64(3): 232-236.
[56]Abrahams A, Parker MI, Prince S. The T-box transcription factor Tbx2: its role in development and possible implication in cancer. IUBMB Life. 2010;62(2):92-102.
[57]Prince S, Carreira S, Vance KW,et al. Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor. Cancer Res. 2004;64(5):1669-1674.
[58]Todorovich SM, Khan ZA. Elevated T-box 2 in infantile hemangioma stem cells maintains an adipogenic differentiation-competent state. Dermatoendocrinol. 2013;5(3): 352-357.
[59]Roach EE, Chakrabarti R, Park NI, et al. Intrinsic regulation of hemangioma involution by platelet-derived growth factor. Cell Death Dis. 2012;3:e328. |